{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:07Z","timestamp":1707524887604},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,18]]},"DOI":"10.7759\/cureus.33927","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T16:49:00Z","timestamp":1674060540000},"source":"Crossref","is-referenced-by-count":0,"title":["Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States"],"prefix":"10.7759","author":[{"given":"Anjali","family":"Sharathkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali G","family":"Mokdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/320674","article-title":"Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder","volume":"2014","author":"Sakurai Y","year":"2014","unstructured":"Sakurai Y, Takeda T. Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res. 2014, 2014:320674. 10.1155\/2014\/320674","journal-title":"J Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"Collins PW","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, et al.. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007, 109:1870-7. 10.1182\/blood-2006-06-029850","journal-title":"Blood"},{"key":"ref3","article-title":"The management of hemophilia in elderly patients","volume":"2","author":"Franchini M","year":"2007","unstructured":"Franchini M, Tagliaferri A, Mannucci PM. The management of hemophilia in elderly patients. Clin Interv Aging. 2007, 2:361-8.","journal-title":"Clin Interv Aging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1315757","article-title":"Acquired inhibitors of coagulation factors: part I-acquired hemophilia A","volume":"38","author":"Coppola A","year":"2012","unstructured":"Coppola A, Favaloro EJ, Tufano A, Di Minno MN, Cerbone AM, Franchini M. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost. 2012, 38:433-46. 10.1055\/s-0032-1315757","journal-title":"Semin Thromb Hemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-161","article-title":"Consensus recommendations for the diagnosis and treatment of acquired hemophilia A","volume":"3","author":"Collins P","year":"2010","unstructured":"Collins P, Baudo F, Huth-K\u00fchne A, et al.. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010, 3:161. 10.1186\/1756-0500-3-161","journal-title":"BMC Res Notes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl P","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F, et al.. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012, 10:622-31. 10.1111\/j.1538-7836.2012.04654.x","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1972.tb03467.x","article-title":"The mode of action of antibodies which destroy factor VIII. I. antibodies which have second-order concentration graphs","volume":"23","author":"Biggs R","year":"1972","unstructured":"Biggs R, Austen DE, Denson KW, Rizza CR, Borrett R. The mode of action of antibodies which destroy factor VIII. I. antibodies which have second-order concentration graphs. Br J Haematol. 1972, 23:125-35. 10.1111\/j.1365-2141.1972.tb03467.x","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres R","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F, et al.. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017, 92:695-705. 10.1002\/ajh.24777","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede A","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, et al.. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020, 105:1791-801. 10.3324\/haematol.2019.230771","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S77332","article-title":"Acquired hemophilia A: emerging treatment options","volume":"6","author":"Janbain M","year":"2015","unstructured":"Janbain M, Leissinger CA, Kruse-Jarres R. Acquired hemophilia A: emerging treatment options. J Blood Med. 2015, 6:143-50. 10.2147\/JBM.S77332","journal-title":"J Blood Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth-K\u00fchne A","year":"2009","unstructured":"Huth-K\u00fchne A, Baudo F, Collins P, et al.. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009, 94:566-75. 10.3324\/haematol.2008.001743","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.916783","article-title":"Emicizumab use in treatment of acquired hemophilia A: a case report","volume":"20","author":"Al-Banaa K","year":"2019","unstructured":"Al-Banaa K, Alhillan A, Hawa F, et al.. Emicizumab use in treatment of acquired hemophilia A: a case report. Am J Case Rep. 2019, 20:1046-8. 10.12659\/AJCR.916783","journal-title":"Am J Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2017.11929642","article-title":"Treatment of chronic lymphocytic leukemia\/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia","volume":"30","author":"Williams C","year":"2017","unstructured":"Williams C, Cable C, Choi J. Treatment of chronic lymphocytic leukemia\/small lymphocytic lymphoma presenting simultaneously with acquired hemophilia and warm autoimmune hemolytic anemia. Proc (Bayl Univ Med Cent). 2017, 30:343-5. 10.1080\/08998280.2017.11929642","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.06.022","article-title":"Acquired hemophilia A after nivolumab therapy in a patient with metastatic squamous cell carcinoma of the lung successfully managed with rituximab","volume":"20","author":"Gokozan HN","year":"2019","unstructured":"Gokozan HN, Friedman JD, Schmaier AH, Downes KA, Farah LA, Reeves HM. Acquired hemophilia A after nivolumab therapy in a patient with metastatic squamous cell carcinoma of the lung successfully managed with rituximab. Clin Lung Cancer. 2019, 20:e560-3. 10.1016\/j.cllc.2019.06.022","journal-title":"Clin Lung Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9152","article-title":"Pulmonary embolism in acquired hemophilia A: a rare complication with factor VIII inhibitor bypassing activity therapy","volume":"12","author":"Aslam HM","year":"2020","unstructured":"Aslam HM, Chong T, Park J, Nicolosi T, Shah R. Pulmonary embolism in acquired hemophilia A: a rare complication with factor VIII inhibitor bypassing activity therapy. Cureus. 2020, 12:e9152. 10.7759\/cureus.9152","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230798","article-title":"Acquired haemophilia a secondary to multiple myeloma: management of a patient with a mechanical mitral valve","volume":"13","author":"Pinchover LB","year":"2020","unstructured":"Pinchover LB, Alsharif R, Bernal T. Acquired haemophilia a secondary to multiple myeloma: management of a patient with a mechanical mitral valve. BMJ Case Rep. 2020, 13:10.1136\/bcr-2019-230798","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.922326","article-title":"Utilization of emicizumab in acquired factor VIII deficiency","volume":"21","author":"Hess KJ","year":"2020","unstructured":"Hess KJ, Patel P, Joshi AM, Kotkiewicz A. Utilization of emicizumab in acquired factor VIII deficiency. Am J Case Rep. 2020, 21:e922326. 10.12659\/AJCR.922326","journal-title":"Am J Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16803","article-title":"Acquired hemophilia A in peripartum period: diagnostic and therapeutic dilemma","volume":"13","author":"Bin Waqar SH","year":"2021","unstructured":"Bin Waqar SH, Khoury L, Hussain A, McFarlane IM. Acquired hemophilia A in peripartum period: diagnostic and therapeutic dilemma. Cureus. 2021, 13:e16803. 10.7759\/cureus.16803","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2018.1487246","article-title":"A case of acquired hemophilia A in an elderly female","volume":"8","author":"Kaur K","year":"2018","unstructured":"Kaur K, Kalla A. A case of acquired hemophilia A in an elderly female. J Community Hosp Intern Med Perspect. 2018, 8:237-40. 10.1080\/20009666.2018.1487246","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1260","article-title":"A unique presentation of spontaneous compartment syndrome due to acquired hemophilia A and associated malignancy: case report and literature review","volume":"11","author":"Alidoost M","year":"2020","unstructured":"Alidoost M, Conte GA, Chaudry R, Nahum K, Marchesani D. A unique presentation of spontaneous compartment syndrome due to acquired hemophilia A and associated malignancy: case report and literature review. World J Oncol. 2020, 11:72-5. 10.14740\/wjon1260","journal-title":"World J Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X20906743","article-title":"Acquired factor VIII deficiency in prostate adenocarcinoma presenting as multiple hematomas and hemarthrosis","volume":"8","author":"Lewis A","year":"2020","unstructured":"Lewis A, Joseph J, Pathak N, Baseri B, Luhrs C. Acquired factor VIII deficiency in prostate adenocarcinoma presenting as multiple hematomas and hemarthrosis. SAGE Open Med Case Rep. 2020, 8:2050313X20906743. 10.1177\/2050313X20906743","journal-title":"SAGE Open Med Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10188","article-title":"Undiagnosed acquired hemophilia A: presenting as recurrent gastrointestinal bleeding","volume":"12","author":"Roy AM","year":"2020","unstructured":"Roy AM, Siddiqui A, Venkata A. Undiagnosed acquired hemophilia A: presenting as recurrent gastrointestinal bleeding. Cureus. 2020, 12:e10188. 10.7759\/cureus.10188","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242876","article-title":"Acquired haemophilia A: successful treatment of a patient using upfront immunosuppressive therapy and haemostatic agents","volume":"14","author":"Chung SY","year":"2021","unstructured":"Chung SY, Shen JG, Sticco KL. Acquired haemophilia A: successful treatment of a patient using upfront immunosuppressive therapy and haemostatic agents. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-242876","journal-title":"BMJ Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102830","article-title":"Newly acquired factor VIII deficiency in a male ex-smoker - a case report","volume":"70","author":"Singh P","year":"2021","unstructured":"Singh P, Gorman B, Abdelsayed N, Faris M. Newly acquired factor VIII deficiency in a male ex-smoker - a case report. Ann Med Surg (Lond). 2021, 70:102830. 10.1016\/j.amsu.2021.102830","journal-title":"Ann Med Surg (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1836726","article-title":"Acquired Hemophilia A and urothelial carcinoma","volume":"11","author":"Taza F","year":"2021","unstructured":"Taza F, Suleman N, Paz R, Haas C. Acquired Hemophilia A and urothelial carcinoma. J Community Hosp Intern Med Perspect. 2021, 11:89-93. 10.1080\/20009666.2020.1836726","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2017.08.005","article-title":"Initial manifestation of acquired hemophilia A after a routine tooth extraction. A case report and literature review","volume":"76","author":"Bennetts NA","year":"2018","unstructured":"Bennetts NA, Mergelmeyer JE, Reimer EJ, Melville JC. Initial manifestation of acquired hemophilia A after a routine tooth extraction. A case report and literature review. J Oral Maxillofac Surg. 2018, 76:490-4. 10.1016\/j.joms.2017.08.005","journal-title":"J Oral Maxillofac Surg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/2324709618817572","article-title":"Acquired hemophilia A presenting as intramuscular hematoma","volume":"6","author":"Al-Shbool G","year":"2018","unstructured":"Al-Shbool G, Vakiti A. Acquired hemophilia A presenting as intramuscular hematoma. J Investig Med High Impact Case Rep. 2018, 6:2324709618817572. 10.1177\/2324709618817572","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcps1500127","article-title":"Clinical problem-solving. A bruising loss","volume":"375","author":"Gibson CJ","year":"2016","unstructured":"Gibson CJ, Berliner N, Miller AL, Loscalzo J. Clinical problem-solving. A bruising loss. N Engl J Med. 2016, 375:76-81. 10.1056\/NEJMcps1500127","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3402\/jchimp.v6.32461","article-title":"Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer","volume":"6","author":"Sheth C","year":"2016","unstructured":"Sheth C, Gill A, Sekhon S. Life-threatening hemorrhage from acquired hemophilia A as a presenting manifestation of prostate cancer. J Community Hosp Intern Med Perspect. 2016, 6:32461. 10.3402\/jchimp.v6.32461","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8744","article-title":"Acquired hemophilia A: a potentially fatal bleeding disorder","volume":"12","author":"Singh N","year":"2020","unstructured":"Singh N, Singh Lubana S, Dabrowski L. Acquired hemophilia A: a potentially fatal bleeding disorder. Cureus. 2020, 12:e8744. 10.7759\/cureus.8744","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-017-2767-6","article-title":"Acquired Hemophilia A in an advanced age patient of hispanic origin: a case report","volume":"10","author":"Rivera Cora NI","year":"2017","unstructured":"Rivera Cora NI, Irizarry Delgado F, Merle Ram\u00edrez SM, Vera Qui\u00f1ones J. Acquired Hemophilia A in an advanced age patient of hispanic origin: a case report. BMC Res Notes. 2017, 10:438. 10.1186\/s13104-017-2767-6","journal-title":"BMC Res Notes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14132","article-title":"Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism","volume":"57","author":"Wool GD","year":"2017","unstructured":"Wool GD, Chapel D, Treml A, Miller JL. Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism. Transfusion. 2017, 57:1827-32. 10.1111\/trf.14132","journal-title":"Transfusion"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.12659\/ajcr.895316","article-title":"A hematological menace: multiple venous thrombosis complicated by acquired factor VIII deficiency","volume":"17","author":"Paudel R","year":"2016","unstructured":"Paudel R, Dominguez LW, Dogra P, Suman S, Badin S, Wasserman C. A hematological menace: multiple venous thrombosis complicated by acquired factor VIII deficiency. Am J Case Rep. 2016, 17:214-8. 10.12659\/ajcr.895316","journal-title":"Am J Case Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019826474","article-title":"Acquired hemophilia A: a case report","volume":"33","author":"Shen M","year":"2020","unstructured":"Shen M, Wang S, Sessa J, Hanna A, Axelrad A, Ali F. Acquired hemophilia A: a case report. J Pharm Pract. 2020, 33:562-6. 10.1177\/0897190019826474","journal-title":"J Pharm Pract"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217198","article-title":"Acquired haemophilia A: an unusual postoperative complication","volume":"2016","author":"Arora S","year":"2016","unstructured":"Arora S, Goyal G, Sarmad R, Wool KJ. Acquired haemophilia A: an unusual postoperative complication. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2016-217198","journal-title":"BMJ Case Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S325031","article-title":"Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders","volume":"12","author":"Valentino LA","year":"2021","unstructured":"Valentino LA, Baker JR, Butler R, et al.. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med. 2021, 12:897-911. 10.2147\/JBM.S325031","journal-title":"J Blood Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S35272","article-title":"Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey","volume":"5","author":"Reding MT","year":"2012","unstructured":"Reding MT, Cooper DL. Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey. J Multidiscip Healthc. 2012, 5:277-87. 10.2147\/JMDH.S35272","journal-title":"J Multidiscip Healthc"},{"key":"ref38","article-title":"Anti-Inhibitor Coagulant Complex (FEIBA) [prescribing information]. (2013). Accessed: January 20","year":"2013","unstructured":"Highlights of Prescribing Information. Anti-Inhibitor Coagulant Complex (FEIBA). Baxter Healthcare Corporation, Westlake Village, California; 2013. https:\/\/www.fda.gov\/media\/78852\/download."},{"key":"ref39","article-title":"Coagulation Factor VIIa Recombinant (NovoSeven RT) [prescribing information]. (2006). Accessed: January 20","year":"2006","unstructured":"NovoSeven\u00ae Coagulation Factor VIIa (Recombinant) [Prescribing Information]. Novo Nordisk Inc., Princeton, New Jersey; 2006. https.\/\/www.fda.gov\/media\/70435\/download."},{"key":"ref40","article-title":"Antihemophilic factor (recombinant), porcine sequence (OBIZUR) [prescribing information]","year":"2020","unstructured":"OBIZUR- Antihemophilic Factor (Recombinant), Porcine Sequence. Highlights of Prescribing Information. Baxalta US Inc., Bannockburn, Illinois; 2020. https:\/\/www.accessdata.fda.gov\/spl\/data\/74c0690d-90f5-46a6-8721-67596cc4cb5b\/74c0690d-90f5-46a6-8721-67596cc4cb5b.xml."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002977","article-title":"Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort","volume":"4","author":"Ellsworth P","year":"2020","unstructured":"Ellsworth P, Chen SL, Kasthuri RS, Key NS, Mooberry MJ, Ma AD. Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort. Blood Adv. 2020, 4:6240-9. 10.1182\/bloodadvances.2020002977","journal-title":"Blood Adv"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12627","article-title":"Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A","volume":"21","author":"Kruse-Jarres R","year":"2015","unstructured":"Kruse-Jarres R, St-Louis J, Greist A, et al.. Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A. Haemophilia. 2015, 21:162-70. 10.1111\/hae.12627","journal-title":"Haemophilia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12873","article-title":"Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(\u00ae) in prophylactic therapy","volume":"22","author":"Varadi K","year":"2016","unstructured":"Varadi K, Tangada S, Loeschberger M, Montsch P, Schrenk G, Ewenstein B, Turecek PL. Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(\u00ae) in prophylactic therapy. Haemophilia. 2016, 22:615-24. 10.1111\/hae.12873","journal-title":"Haemophilia"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13040","article-title":"Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients","volume":"23","author":"Tarantino MD","year":"2017","unstructured":"Tarantino MD, Cuker A, Hardesty B, Roberts JC, Sholzberg M. Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients. Haemophilia. 2017, 23:25-32. 10.1111\/hae.13040","journal-title":"Haemophilia"},{"key":"ref45","article-title":"Assessment of interference by emicizumab in the measurement of susoctocog alfa factor VIII activity using a chromogenic assay [Abstract]","author":"Pan L","year":"2022","unstructured":"Pan L, Mokdad A, Turecek P, Robinson M, Jain N. Assessment of interference by emicizumab in the measurement of susoctocog alfa factor VIII activity using a chromogenic assay [Abstract]. ISTH Congress Abstracts. 2022,","journal-title":"ISTH Congress Abstracts"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14556","article-title":"Emicizumab and thrombosis: the story so far","volume":"17","author":"Makris M","year":"2019","unstructured":"Makris M, Iorio A, Lenting PJ. Emicizumab and thrombosis: the story so far. J Thromb Haemost. 2019, 17:1269-72. 10.1111\/jth.14556","journal-title":"J Thromb Haemost"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25865","article-title":"The first case of acquired hemophilia A associated with SARS-CoV-2 infection","volume":"95","author":"Franchini M","year":"2020","unstructured":"Franchini M, Glingani C, De Donno G, et al.. The first case of acquired hemophilia A associated with SARS-CoV-2 infection. Am J Hematol. 2020, 95:E197-8. 10.1002\/ajh.25865","journal-title":"Am J Hematol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16254","article-title":"De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection","volume":"61","author":"Olsen GM","year":"2021","unstructured":"Olsen GM, Rinder HM, Tormey CA. De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection. Transfusion. 2021, 61:989-91. 10.1111\/trf.16254","journal-title":"Transfusion"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16579","article-title":"A case of acquired hemophilia A following SARS-CoV-2 infection","volume":"13","author":"Hafzah H","year":"2021","unstructured":"Hafzah H, McGuire C, Hamad A. A case of acquired hemophilia A following SARS-CoV-2 infection. Cureus. 2021, 13:e16579. 10.7759\/cureus.16579","journal-title":"Cureus"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242884","article-title":"Severe acquired haemophilia associated with asymptomatic SARS-CoV-2 infection","volume":"14","author":"Wang KY","year":"2021","unstructured":"Wang KY, Shah P, Roarke DT, Shakil SA. Severe acquired haemophilia associated with asymptomatic SARS-CoV-2 infection. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-242884","journal-title":"BMJ Case Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms J","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"ref52","unstructured":"MASAC Document 257 - Guidelines for Emergency Department Management of Individuals with Hemophilia and Other Bleeding Disorders. (2019). Accessed. January 20, 2021: https:\/\/www.hemophilia.org\/healthcare-professionals\/guidelines-on-care\/masac-documents\/masac-document-257-guidelines-...."},{"key":"ref53","unstructured":"MASAC Document 265 - MASAC Guidelines for Pregnancy and Perinatal Management of Women with Inherited Bleeding Disorders and Carriers of Hemophilia A or B. (2021). Accessed. January 20, 2021: https:\/\/www.hemophilia.org\/healthcare-professionals\/guidelines-on-care\/masac-documents\/masac-document-265-masac-guide...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128274-review-of-potential-barriers-to-effective-hemostatic-management-of-acquired-hemophilia-a-by-non-hemophilia-experts-in-the-united-states","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:52Z","timestamp":1707508132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128274-review-of-potential-barriers-to-effective-hemostatic-management-of-acquired-hemophilia-a-by-non-hemophilia-experts-in-the-united-states"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.33927","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}